An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Reference83 articles.
1. Rational Use of New and Existing Disease-Modifying Agents in Rheumatoid Arthritis
2. Use of Biologics for Rheumatoid Arthritis Tempered by Concerns Over Safety, Cost
3. Direct medical costs and their predictors in patients with rheumatoid arthritis
4. A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis
5. Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amelioration of Freund Complete Adjuvant-induced Rheumatoid Arthritis by Formulated Solid Lipid Nanoparticle of α-Mangostin in Rat Model;Journal of Young Pharmacists;2023-08-25
2. Health Economics in Rheumatology: A Felt Need in India;Indian Journal of Rheumatology;2022
3. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis;Journal of Managed Care & Specialty Pharmacy;2021-01
4. Anti-Arthritic Effect of Garcinol Enriched Fraction Against Adjuvant Induced Arthritis;Recent Patents on Inflammation & Allergy Drug Discovery;2019-08-05
5. Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis;Current Rheumatology Reports;2017-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3